We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.78%
2 Healthcare 3.27%
3 Industrials 2.02%
4 Financials 2.02%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPT
9876
CALL
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$135K ﹤0.01%
56,900
+28,000
+97% +$56.5K
CAAS icon
9877
PUT
China Automotive Systems
CAAS
$142M
$135K ﹤0.01%
+21,700
New +$100K
CABA icon
9878
Cabaletta Bio
CABA
$448M
$135K ﹤0.01%
+10,809
New +$140K
DHT icon
9879
CALL
DHT Holdings
DHT
$3.14B
$135K ﹤0.01%
25,800
-61,700
-71% -$322K
FTEK icon
9880
Fuel Tech
FTEK
$45.3M
$134K ﹤0.01%
+34,618
New +$78.6K
VLRS
9881
PUT
Controladora Vuela Compania de Aviacion
VLRS
$906M
$134K ﹤0.01%
10,800
-100
-0.9% -$980
CNR
9882
PUT
Core Natural Resources Inc
CNR
$4.76B
$134K ﹤0.01%
18,600
+2,200
+13% +$11.5K
ETTX
9883
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$134K ﹤0.01%
+54,116
New +$106K
EVFM
9884
CALL
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$134K ﹤0.01%
3,700
+920
+33% +$33.3K
AEI icon
9885
Alset
AEI
$52.1M
$133K ﹤0.01%
+1,113
New +$125K
CLMT icon
9886
PUT
Calumet Specialty Products
CLMT
$4.19B
$133K ﹤0.01%
42,400
-1,700
-4% -$5.93K
FCF icon
9887
CALL
First Commonwealth Financial
FCF
$2.18B
$133K ﹤0.01%
+12,200
New +$117K
CBIO
9888
CALL
Crescent Biopharma
CBIO
$637M
$133K ﹤0.01%
354
-146
-29% -$51.2K
LOMA
9889
Loma Negra
LOMA
$1.1B
$133K ﹤0.01%
+21,594
New +$111K
ORN icon
9890
Orion Group Holdings
ORN
$402M
$133K ﹤0.01%
26,833
-8,552
-24% -$33.2K
RIGL icon
9891
CALL
Rigel Pharmaceuticals
RIGL
$795M
$133K ﹤0.01%
3,810
-760
-17% -$22K
SENS icon
9892
Senseonics Holdings Inc
SENS
$413M
$133K ﹤0.01%
+7,608
New +$66.2K
ZAGG
9893
PUT
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$133K ﹤0.01%
31,800
+14,200
+81% +$49.8K
IMDX
9894
Insight Molecular Diagnostics
IMDX
$141M
$132K ﹤0.01%
2,767
+1,896
+218% +$69.6K
QH
9895
Quhuo Limited Class A Ordinary Shares
QH
$11.9M
$132K ﹤0.01%
+19
New +$126K
TEO icon
9896
PUT
Telecom Argentina
TEO
$5.75B
$132K ﹤0.01%
20,100
+900
+5% +$6.65K
RTLR
9897
PUT
DELISTED
Rattler Midstream LP Common Units
RTLR
$132K ﹤0.01%
13,900
-1,200
-8% -$9.45K
RNWK
9898
CALL
DELISTED
RealNetworks Inc
RNWK
$132K ﹤0.01%
84,900
+65,400
+335% +$96K
ADIL
9899
Adial Pharmaceuticals
ADIL
$8.71M
$131K ﹤0.01%
+123
New +$145K
CLMT icon
9900
CALL
Calumet Specialty Products
CLMT
$4.19B
$131K ﹤0.01%
41,900
+8,300
+25% +$28.9K

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.